Home Healthcare Pharmaceuticals Tuberculosis Drugs Market

Tuberculosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Isoniazid, Rifampin, Ethambutol, Pyrazinamide, Fluoroquinolones, Bedaquiline, Pretomanid, Delamanid, Aminoglycosides, Thioamides, Cyclic Peptides, Other Drug Classes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies, Other Distribution Channels) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 06, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Tuberculosis Drugs Market Size Analysis
    1. Introduction
    2. Tuberculosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Isoniazid
      2. Rifampin
      3. Ethambutol
      4. Pyrazinamide
      5. Fluoroquinolones
      6. Bedaquiline
      7. Pretomanid
      8. Delamanid
      9. Aminoglycosides
      10. Thioamides
      11. Cyclic Peptides
      12. Other Drug Classes
    3. Tuberculosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Other Distribution Channels
  7. North America Tuberculosis Drugs Market Size Analysis
    1. Introduction
    2. Tuberculosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Isoniazid
      2. Rifampin
      3. Ethambutol
      4. Pyrazinamide
      5. Fluoroquinolones
      6. Bedaquiline
      7. Pretomanid
      8. Delamanid
      9. Aminoglycosides
      10. Thioamides
      11. Cyclic Peptides
      12. Other Drug Classes
    3. Tuberculosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Other Distribution Channels
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
  8. Europe Tuberculosis Drugs Market Size Analysis
    1. Introduction
    2. Tuberculosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Isoniazid
      2. Rifampin
      3. Ethambutol
      4. Pyrazinamide
      5. Fluoroquinolones
      6. Bedaquiline
      7. Pretomanid
      8. Delamanid
      9. Aminoglycosides
      10. Thioamides
      11. Cyclic Peptides
      12. Other Drug Classes
    3. Tuberculosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Other Distribution Channels
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    6. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
  9. APAC Tuberculosis Drugs Market Size Analysis
    1. Introduction
    2. Tuberculosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Isoniazid
      2. Rifampin
      3. Ethambutol
      4. Pyrazinamide
      5. Fluoroquinolones
      6. Bedaquiline
      7. Pretomanid
      8. Delamanid
      9. Aminoglycosides
      10. Thioamides
      11. Cyclic Peptides
      12. Other Drug Classes
    3. Tuberculosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Other Distribution Channels
    4. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    7. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    9. Singapore
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
  10. Middle East and Africa Tuberculosis Drugs Market Size Analysis
    1. Introduction
    2. Tuberculosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Isoniazid
      2. Rifampin
      3. Ethambutol
      4. Pyrazinamide
      5. Fluoroquinolones
      6. Bedaquiline
      7. Pretomanid
      8. Delamanid
      9. Aminoglycosides
      10. Thioamides
      11. Cyclic Peptides
      12. Other Drug Classes
    3. Tuberculosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Other Distribution Channels
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
  11. LATAM Tuberculosis Drugs Market Size Analysis
    1. Introduction
    2. Tuberculosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Isoniazid
      2. Rifampin
      3. Ethambutol
      4. Pyrazinamide
      5. Fluoroquinolones
      6. Bedaquiline
      7. Pretomanid
      8. Delamanid
      9. Aminoglycosides
      10. Thioamides
      11. Cyclic Peptides
      12. Other Drug Classes
    3. Tuberculosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Other Distribution Channels
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
  12. Competitive Landscape
    1. Tuberculosis Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Johnson & Johnson Services Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Otsuka Pharmaceutical Co., Ltd.
    3. Lupin Limited
    4. Macleods Pharmaceuticals Ltd.
    5. Viatris Inc.
    6. Novartis AG
    7. Sanofi
    8. Pfizer Inc.
    9. Cadila Healthcare
    10. Cipla Ltd.
    11. Hetero Labs Ltd.
    12. Sandoz AG
    13. Strides Pharma Science Ltd.
    14. Shanghai Fosun Pharmaceutical Group
    15. Hikma Pharmaceuticals
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.